Works by Lim, Hyeong-Seok


Results: 50
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Safety and efficacy of selumetinib in pediatric and adult patients with neurofibromatosis type 1 and plexiform neurofibroma.

    Published in:
    Neuro-Oncology, 2024, v. 26, n. 12, p. 2352, doi. 10.1093/neuonc/noae121
    By:
    • Kim, Hyery;
    • Yoon, Hee Mang;
    • Kim, Eun Key;
    • Ra, Young Shin;
    • Kim, Hyo-Won;
    • Yum, Mi-Sun;
    • Kim, Min-Jee;
    • Baek, Jae Suk;
    • Sung, Yu Sub;
    • Lee, Sang Min;
    • Lim, Hyeong-Seok;
    • Lee, Byung Joo;
    • Lim, Hyun Taek;
    • Kim, Dohyung;
    • Yoon, Jihee;
    • Bae, Hyunwoo;
    • Hwang, Soojin;
    • Choi, Yun-Ha;
    • Kim, Kyung Ah;
    • Choi, In Hee
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24

    A phase 1 dose-escalation and dose-expansion study to assess the safety and efficacy of CKD-516, a novel vascular disrupting agent, in combination with Irinotecan in patients with previously treated metastatic colorectal cancer.

    Published in:
    Investigational New Drugs, 2021, v. 39, n. 5, p. 1335, doi. 10.1007/s10637-021-01110-9
    By:
    • Jeong, Hyehyun;
    • Hong, Yong Sang;
    • Kim, Jeong Eun;
    • Lim, Hyeong-Seok;
    • Ahn, Joong Bae;
    • Shin, Sang Joon;
    • Park, Young Suk;
    • Kim, Seung Tae;
    • Han, Sae-Won;
    • Kim, Tae-You;
    • Kim, Tae Won
    Publication type:
    Article
    25
    26
    27

    Pharmacokinetic equivalence of CT‐P17 to high‐concentration (100 mg/ml) reference adalimumab: A randomized phase I study in healthy subjects.

    Published in:
    CTS: Clinical & Translational Science, 2021, v. 14, n. 4, p. 1280, doi. 10.1111/cts.12967
    By:
    • Yu, Kyung‐Sang;
    • Jang, In‐Jin;
    • Lim, Hyeong‐Seok;
    • Hong, Jang Hee;
    • Kim, Min‐Gul;
    • Park, Min Kyu;
    • Cho, Doo‐Yeoun;
    • Park, Min Soo;
    • Chung, Jae Yong;
    • Ghim, Jong‐Lyul;
    • Lee, SeungHwan;
    • Yoon, Seok Kyu;
    • Kwon, In Sun;
    • Lee, Sang Joon;
    • Kim, Sung Hyun;
    • Bae, Yun Ju;
    • Cha, Jung Bin;
    • Furst, Daniel E.;
    • Keystone, Edward;
    • Kay, Jonathan
    Publication type:
    Article
    28

    A phase II study of perioperative S-1 combined with weekly docetaxel in patients with locally advanced gastric carcinoma: clinical outcomes and clinicopathological and pharmacogenetic predictors for survival.

    Published in:
    Gastric Cancer, 2016, v. 19, n. 2, p. 586, doi. 10.1007/s10120-015-0490-3
    By:
    • Kim, Young-Woo;
    • Kim, Mi-Jung;
    • Ryu, Keun;
    • Lim, Hyeong-Seok;
    • Lee, Jun;
    • Kong, Sun-Young;
    • Lee, Jong;
    • Choi, Il;
    • Kim, Chan;
    • Cho, Soo-Jeong;
    • Kook, Myeong-Cherl;
    • Park, Young-Iee;
    • Kim, Seok-Ki;
    • Park, Sook
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42

    Effects of Renal Impairment on the Pharmacokinetics and Safety of Udenafil.

    Published in:
    Journal of Clinical Pharmacology, 2018, v. 58, n. 7, p. 905, doi. 10.1002/jcph.1095
    By:
    • Cho, Yong‐Soon;
    • Noh, Yook‐Hwan;
    • Lim, Hyeong‐Seok;
    • Cho, Sang‐Heon;
    • Ghim, Jong‐Lyul;
    • Choe, Sangmin;
    • Kim, Soon‐Bae;
    • Park, Jung‐Sik;
    • Lee, Sang‐Koo;
    • Yang, Won‐Seok;
    • Chang, Jai‐Won;
    • Bahng, Mi‐Young;
    • Bae, Kyun‐Seop
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49
    50